TNDM - TANDEM DIABETES CARE INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care Inc. (NASDAQ: TNDM) | Benzinga
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
- Did you purchase your shares between August 3, 2022 and November 2, 2022, inclusive?
- Did you lose money in your investment in Tandem Diabetes Care, Inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ:TNDM) between August 3, 2022 and November 2, 2022, inclusive (the "Class Period"). The lawsuit was filed in the United States District Court for the Southern District of California and alleges violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint").
If you purchased or acquired Tandem securities, and/or would like to discuss your legal rights and options please visit Tandem Diabetes Care, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or TNDM)>Full story available on Benzinga.com